Extracellular matrix and the development of disease: The role of its components in cancer progression

Advances in Developmental Biology

Volumn 15, Issue , 2005, Pages 203-228

  Zent, Roy ^a   Pozzi, Ambra ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750915458     PISSN: 15743349     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1574-3349(05)15007-8     Document Type: Review

References (170)

1. Abe N., Muragaki Y., Yoshioka H., Inoue H., and Ninomiya Y. Identification of a novel collagen chain represented by extensive interruptions in the triple-helical region. Biochem. Biophys. Res. Commun. 196 (1993) 576-582
2. Amenta P.S., Briggs K., Xu K., Gamboa E., Jukkola A.F., Li D., and Myers J.C. Type XV collagen in human colonic adenocarcinomas has a different distribution than other basement membrane zone proteins. Hum. Pathol. 31 (2000) 359-366
3. Amenta P.S., Hadad S., Lee M.T., Barnard N., Li D., and Myers J.C. Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast. J. Pathol. 199 (2003) 298-308
4. Aumailley M., El Khal A., Knoss N., and Tunggal L. Laminin 5 processing and its integration into the ECM. Matrix Biol. 22 (2003) 49-54
5. Barr L.F., Campbell S.E., Bochner B.S., and Dang C.V. Association of the decreased expression of alpha3beta1 integrin with the altered cell: Environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells. Cancer Res. 58 (1998) 5537-5545
6. Beck K., Hunter I., and Engel J. Structure and function of laminin: Anatomy of a multidomain glycoprotein. FASEB J. 4 (1990) 148-160
7. Behrendt N. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): Membrane proteins engaged in matrix turnover during tissue remodeling. Biol. Chem. 385 (2004) 103-136
8. Berquin I.M., and Sloane B.F. Cathepsin B expression in human tumors. Adv. Exp. Med. Biol. 389 (1996) 281-294
9. Bissell M.J., Radisky D.C., Rizki A., Weaver V.M., and Petersen O.W. The organizing principle: Microenvironmental influences in the normal and malignant breast. Differentiation 70 (2002) 537-546
10. Borza D.B., Bondar O., Ninomiya Y., Sado Y., Naito I., Todd P., and Hudson B.G. The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes. J. Biol. Chem. 276 (2001) 28532-28540
11. Borza D.B., Bondar O., Todd P., Sundaramoorthy M., Sado Y., Ninomiya Y., and Hudson B.G. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains. J. Biol. Chem. 277 (2002) 40075-40083
12. Bosman F.T., and Stamenkovic I. Functional structure and composition of the extracellular matrix. J. Pathol. 200 (2003) 423-428
13. Boutaud A., Borza D.B., Bondar O., Gunwar S., Netzer K.O., Singh N., Ninomiya Y., Sado Y., Noelken M.E., and Hudson B.G. Type IV collagen of the glomerular basement membrane. Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J. Biol. Chem. 275 (2000) 30716-30724
14. Brooks P.C., Montgomery A.M., Rosenfeld M., Reisfeld R.A., Hu T., Klier G., and Cheresh D.A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79 (1994) 1157-1164
15. Brooks P.C., Silletti S., von Schalscha T.L., Friedlander M., and Cheresh D.A. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92 (1998) 391-400
16. Burchardt E.R., Hein R., and Bosserhoff A.K. Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma. Clin. Exp. Dermatol. 28 (2003) 515-520
17. Chelberg M.K., McCarthy J.B., Skubitz A.P., Furcht L.T., and Tsilibary E.C. Characterization of a synthetic peptide from type IV collagen that promotes melanoma cell adhesion, spreading, and motility. J. Cell. Biol. 111 (1990) 261-270
18. Chelberg M.K., Tsilibary E.C., Hauser A.R., and McCarthy J.B. Type IV collagen-mediated melanoma cell adhesion and migration: Involvement of multiple, distinct domains of the collagen molecule. Cancer Res. 49 (1989) 4796-4802
19. Choong P.F., and Nadesapillai A.P. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis. Clin. Orthop. (2003) S46-S58
20. Colorado P.C., Torre A., Kamphaus G., Maeshima Y., Hopfer H., Takahashi K., Volk R., Zamborsky E.D., Herman S., Sarkar P.K., Ericksen M.B., Dhanabal M., Simons M., Post M., Kufe D.W., Weichselbaum R.R., Sukhatme V.P., and Kalluri R. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res. 60 (2000) 2520-2526
21. Cornelius L.A., Nehring L.C., Harding E., Bolanowski M., Welgus H.G., Kobayashi D.K., Pierce R.A., and Shapiro S.D. Matrix metalloproteinases generate angiostatin: Effects on neovascularization. J. Immunol. 161 (1998) 6845-6852
22. Costantini V., Sidoni A., Deveglia R., Cazzato O.A., Bellezza G., Ferri I., Bucciarelli E., and Nenci G.G. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissues. Cancer 77 (1996) 1079-1088
23. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295 (2002) 2387-2392
24. De Wever O., and Mareel M. Role of tissue stroma in cancer cell invasion. J. Pathol. 200 (2003) 429-447
25. Dennhofer R., Kurschat P., Zigrino P., Klose A., Bosserhoff A., van Muijen G., Krieg T., Mauch C., and Hunzelmann N. Invasion of melanoma cells into dermal connective tissue in vitro: Evidence for an important role of cysteine proteases. Int. J. Cancer. 106 (2003) 316-323
26. Dohchin A., Suzuki J.I., Seki H., Masutani M., Shiroto H., and Kawakami Y. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer 89 (2000) 482-487
27. Dong Z., Kumar R., Yang X., and Fidler I.J. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88 (1997) 801-810
28. Dreier R., Grassel S., Fuchs S., Schaumburger J., and Bruckner P. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp. Cell. Res. 297 (2004) 303-312
29. Eble J.A., Golbik R., Mann K., and Kuhn K. The alpha 1 beta 1 integrin recognition site of the basement membrane collagen molecule [alpha 1(IV)]2 alpha 2(IV). EMBO J. 12 (1993) 4795-4802
30. Engbring J.A., Hoffman M.P., Karmand A.J., and Kleinman H.K. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan. Cancer Res. 62 (2002) 3549-3554
31. Engbring J.A., and Kleinman H.K. The basement membrane matrix in malignancy. J. Pathol. 200 (2003) 465-470
32. Eriksson K., Magnusson P., Dixelius J., Claesson-Welsh L., and Cross M.J. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett. 536 (2003) 19-24
33. Fawzi A., Robinet A., Monboisse J.C., Ziaie Z., Kefalides N.A., and Bellon G. A peptide of the alpha 3(IV) chain of type IV collagen modulates stimulated neutrophil function via activation of cAMP-dependent protein kinase and Ser/Thr protein phosphatase. Cell Signal 12 (2000) 327-335
34. Felbor U., Dreier L., Bryant R.A., Ploegh H.L., Olsen B.R., and Mothes W. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19 (2000) 1187-1194
35. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 20 (2003) 203-213
36. Felding-Habermann B., Fransvea E., O'Toole T.E., Manzuk L., Faha B., and Hensler M. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin. Exp. Metastasis 19 (2002) 427-436
37. Ferreras M., Felbor U., Lenhard T., Olsen B.R., and Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 486 (2000) 247-251
38. Floquet N., Pasco S., Ramont L., Derreumaux P., Laronze J.Y., Nuzillard J.M., Maquart F.X., Alix A.J., and Monboisse J.C. The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent. J. Biol. Chem. 279 (2004) 2091-2100
39. Folgueras A.R., Pendas A.M., Sanchez L.M., and Lopez-Otin C. Matrix metalloproteinases in cancer: From new functions to improved inhibition strategies. Int. J. Dev. Biol. 48 (2004) 411-424
40. Freije J.M., Balbin M., Pendas A.M., Sanchez L.M., Puente X.S., and Lopez-Otin C. Matrix metalloproteinases and tumor progression. Adv. Exp. Med. Biol. 532 (2003) 91-107
41. Friedlander M., Brooks P.C., Shaffer R.W., Kincaid C.M., Varner J.A., and Cheresh D.A. Definition of two angiogenic pathways by distinct alpha v integrins. Science 270 (1995) 1500-1502
42. Gehlsen K.R., Davis G.E., and Sriramarao P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin. Exp. Metastasis 10 (1992) 111-120
43. Ghosh S., and Stack M.S. Proteolytic modification of laminins: Functional consequences. Microsc. Res. Tech. 51 (2000) 238-246
44. Giannelli G., Falk-Marzillier J., Schiraldi O., Stetler-Stevenson W.G., and Quaranta V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277 (1997) 225-228
45. Giannelli G., Pozzi A., Stetler-Stevenson W.G., Gardner H.A., and Quaranta V. Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids. Am. J. Pathol. 154 (1999) 1193-1201
46. Goel H.L., and Languino L.R. Integrin signaling in cancer. Cancer Treat. Res. 119 (2004) 15-31
47. Goldfinger L.E., Stack M.S., and Jones J.C. Processing of laminin-5 and its functional consequences: Role of plasmin and tissue-type plasminogen activator. J. Cell. Biol. 141 (1998) 255-265
48. Gordon L.A., Mulligan K.T., Maxwell-Jones H., Adams M., Walker R.A., and Jones J.L. Breast cell invasive potential relates to the myoepithelial phenotype. Int. J. Cancer 106 (2003) 8-16
49. Halfter W., Dong S., Schurer B., and Cole G.J. Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273 (1998) 25404-25412
50. Hamano Y., Zeisberg M., Sugimoto H., Lively J.C., Maeshima Y., Yang C., Hynes R.O., Werb Z., Sudhakar A., and Kalluri R. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3 (2003) 589-601
51. Han J., Ohno N., Pasco S., Monboisse J.C., Borel J.P., and Kefalides N.A. A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells. J. Biol. Chem. 272 (1997) 20395-20401
52. Hao J., Jackson L., Calaluce R., McDaniel K., Dalkin B.L., and Nagle R.B. Investigation into the mechanism of the loss of laminin 5 (alpha3beta3gamma2) expression in prostate cancer. Am. J. Pathol. 158 (2001) 1129-1135
53. Hao J., Yang Y., McDaniel K.M., Dalkin B.L., Cress A.E., and Nagle R.B. Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate. Am. J. Pathol. 149 (1996) 1341-1349
54. He G.A., Luo J.X., Zhang T.Y., Hu Z.S., and Wang F.Y. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. Biochem. Biophys. Res. Commun. 318 (2004) 354-360
55. He G.A., Luo J.X., Zhang T.Y., Wang F.Y., and Li R.F. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. Biochem. Biophys. Res. Commun. 312 (2003) 801-805
56. Hibino S., Shibuya M., Engbring J.A., Mochizuki M., Nomizu M., and Kleinman H.K. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res. 64 (2004) 4810-4816
57. Hiki Y., Iyama K., Tsuruta J., Egami H., Kamio T., Suko S., Naito I., Sado Y., Ninomiya Y., and Ogawa M. Differential distribution of basement membrane type IV collagen alpha1(IV), alpha2(IV), alpha5(IV) and alpha6(IV) chains in colorectal epithelial tumors. Pathol. Int. 52 (2002) 224-233
58. Hintermann E., and Quaranta V. Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. Matrix Biol. 23 (2004) 75-85
59. Hohenester E., and Engel J. Domain structure and organisation in extracellular matrix proteins. Matrix Biol. 21 (2002) 115-128
60. Hood J.D., and Cheresh D.A. Role of integrins in cell invasion and migration. Nat. Rev. Cancer 2 (2002) 91-100
61. Hostikka S.L., and Tryggvason K. The complete primary structure of the alpha 2 chain of human type IV collagen and comparison with the alpha 1(IV) chain. J. Biol. Chem. 263 (1988) 19488-19493
62. Hsu M.Y., Meier F., and Herlyn M. Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70 (2002) 522-536
63. Hynes R. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
64. Jiang A., and Pei D. Distinct roles of catalytic and pexin-like domains in membrane-type matrix metalloproteinase (MMP)-mediated pro-MMP-2 activation and collagenolysis. J. Biol. Chem. 278 (2003) 38765-38771
65. Jin H., and Varner J. Integrins: Roles in cancer development and as treatment targets. Br. J. Cancer 90 (2004) 561-565
66. Jones P.A., and De Clerck Y.A. Extracellular matrix destruction by invasive tumor cells. Cancer Metastasis Rev. 1 (1982) 289-317
67. Kagesato Y., Mizushima H., Koshikawa N., Kitamura H., Hayashi H., Ogawa N., Tsukuda M., and Miyazaki K. Sole expression of laminin gamma 2 chain in invading tumor cells and its association with stromal fibrosis in lung adenocarcinomas. Jpn. J. Cancer Res. 92 (2001) 184-192
68. Kamphaus G.D., Colorado P.C., Panka D.J., Hopfer H., Ramchandran R., Torre A., Maeshima Y., Mier J.W., Sukhatme V.P., and Kalluri R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J. Biol. Chem. 275 (2000) 1209-1215
69. Katayama M., and Sekiguchi K. Laminin-5 in epithelial tumour invasion. J. Mol. Histol. 35 (2004) 277-286
70. Kim W.H., Nomizu M., Song S.Y., Tanaka K., Kuratomi Y., Kleinman H.K., and Yamada Y. Laminin-alpha1-chain sequence Leu-Gln-Val-Gln-Leu-Ser-Ile-Arg (LQVQLSIR) enhances murine melanoma cell metastases. Int. J. Cancer 77 (1998) 632-639
71. Kim Y.M., Jang J.W., Lee O.H., Yeon J., Choi E.Y., Kim K.W., Lee S.T., and Kwon Y.G. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res. 60 (2000) 5410-5413
72. Kivirikko S., Saarela J., Myers J.C., Autio-Harmainen H., and Pihlajaniemi T. Distribution of type XV collagen transcripts in human tissue and their production by muscle cells and fibroblasts. Am. J. Pathol. 147 (1995) 1500-1509
73. Kos J., and Lah T.T. Cysteine proteinases and their endogenous inhibitors: Target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol. Rep. 5 (1998) 1349-13461
74. Koshikawa N., Giannelli G., Cirulli V., Miyazaki K., and Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell. Biol. 148 (2000) 615-624
75. Koshikawa N., Schenk S., Moeckel G., Sharabi A., Miyazaki K., Gardner H., Zent R., and Quaranta V. Proteolytic processing of laminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology. FASEB J. 18 (2004) 364-366
76. Krepela E. Cysteine proteinases in tumor cell growth and apoptosis. Neoplasma 48 (2001) 332-349
77. Kreuger J., Matsumoto T., Vanwildemeersch M., Sasaki T., Timpl R., Claesson-Welsh L., Spillmann D., and Lindahl U. Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J. 21 (2002) 6303-6311
78. Krutovskikh V. Implication of direct host-tumor intercellular interactions in non-immune host resistance to neoplastic growth. Semin. Cancer Biol. 12 (2002) 267-276
79. Kuratomi Y., Nomizu M., Nielsen P.K., Tanaka K., Song S.Y., Kleinman H.K., and Yamada Y. Identification of metastasis-promoting sequences in the mouse laminin alpha 1 chain. Exp. Cell. Res. 249 (1999) 386-395
80. Kuratomi Y., Nomizu M., Tanaka K., Ponce M.L., Komiyama S., Kleinman H.K., and Yamada Y. Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells. Br. J. Cancer 86 (2002) 1169-1173
81. Lauer-Fields J.L., Malkar N.B., Richet G., Drauz K., and Fields G.B. Melanoma cell CD44 interaction with the alpha 1(IV)1263-1277 region from basement membrane collagen is modulated by ligand glycosylation. J. Biol. Chem. 278 (2003) 14321-14330
82. Leblond C.P., and Inoue S. Structure, composition, and assembly of basement membrane. Am. J. Anat. 185 (1989) 367-390
83. Lee D.H., Yang Y., Lee S.J., Kim K.Y., Koo T.H., Shin S.M., Song K.S., Lee Y.H., Kim Y.J., Lee J.J., Choi I., and Lee J.H. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system. Cancer Res. 63 (2003) 4648-4655
84. Lee S.J., Jang J.W., Kim Y.M., Lee H.I., Jeon J.Y., Kwon Y.G., and Lee S.T. Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett. 519 (2002) 147-152
85. Leinonen A., Mariyama M., Mochizuki T., Tryggvason K., and Reeders S.T. Complete primary structure of the human type IV collagen alpha 4(IV) chain. Comparison with structure and expression of the other alpha (IV) chains. J. Biol. Chem. 269 (1994) 26172-26177
86. Li D., Clark C.C., and Myers J.C. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J. Biol. Chem. 275 (2000) 22339-22347
87. Lin H.C., Chang J.H., Jain S., Gabison E.E., Kure T., Kato T., Fukai N., and Azar D.T. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2517-2524
88. Lochter A., Navre M., Werb Z., and Bissell M.J. alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol. Biol. Cell 10 (1999) 271-282
89. Lundgren C., Frankendal B., Silfversward C., Nilsson B., Tryggvason K., Auer G., and Nordstrom B. Laminin-5 gamma2-chain expression and DNA ploidy as predictors of prognosis in endometrial carcinoma. Med. Oncol. 20 (2003) 147-156
90. Macpherson G.R., Ng S.S., Forbes S.L., Melillo G., Karpova T., McNally J., Conrads T.P., Veenstra T.D., Martinez A., Cuttitta F., Price D.K., and Figg W.D. Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay. Mol. Cancer Ther. 2 (2003) 845-854
91. Madri J.A., Pratt B.M., Yurchenco P.D., and Furthmayr H. The ultrastructural organization and architecture of basement membranes. Ciba. Found. Symp. 108 (1984) 6-24
92. Maeshima Y., Colorado P.C., and Kalluri R. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J. Biol. Chem. 275 (2000) 23745-23750
93. Maeshima Y., Colorado P.C., Torre A., Holthaus K.A., Grunkemeyer J.A., Ericksen M.B., Hopfer H., Xiao Y., Stillman I.E., and Kalluri R. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J. Biol. Chem. 275 (2000) 21340-21348
94. Maeshima Y., Manfredi M., Reimer C., Holthaus K.A., Hopfer H., Chandamuri B.R., Kharbanda S., and Kalluri R. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J. Biol. Chem. 276 (2001) 15240-15248
95. Maeshima Y., Sudhakar A., Lively J.C., Ueki K., Kharbanda S., Kahn C.R., Sonenberg N., Hynes R.O., and Kalluri R. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 295 (2002) 140-143
96. Maeshima Y., Yerramalla U.L., Dhanabal M., Holthaus K.A., Barbashov S., Kharbanda S., Reimer C., Manfredi M., Dickerson W.M., and Kalluri R. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J. Biol. Chem. 276 (2001) 31959-31968
97. Marcinkiewicz C., Weinreb P.H., Calvete J.J., Kisiel D.G., Mousa S.A., Tuszynski G.P., and Lobb R.R. Obtustatin: A potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo. Cancer Res. 63 (2003) 2020-2023
98. Mariotti A., Kedeshian P.A., Dans M., Curatola A.M., Gagnoux-Palacios L., and Giancotti F.G. EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: Role in epithelial cell migration and carcinoma invasion. J. Cell. Biol. 155 (2001) 447-458
99. Mariyama M., Leinonen A., Mochizuki T., Tryggvason K., and Reeders S.T. Complete primary structure of the human alpha 3(IV) collagen chain. Coexpression of the alpha 3(IV) and alpha 4(IV) collagen chains in human tissues. J. Biol. Chem. 269 (1994) 23013-23017
100. Marneros A.G., and Olsen B.R. The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol. 20 (2001) 337-345
101. Martin K.J., Kwan C.P., Nagasaki K., Zhang X., O'Hare M.J., Kaelin C.M., Burgeson R.E., Pardee A.B., and Sager R. Down-regulation of laminin-5 in breast carcinoma cells. Mol. Med. 4 (1998) 602-613
102. Martinella-Catusse C., Polette M., Noel A., Gilles C., Dehan P., Munaut C., Colige A., Volders L., Monboisse J.C., Foidart J.M., and Birembaut P. Down-Regulation of MT1-MMP expression by the alpha3 chain of type IV collagen inhibits bronchial tumor cell line invasion. Lab. Invest 81 (2001) 167-175
103. Marx J. Angiogenesis. A boost for tumor starvation. Science 301 (2003) 452-454
104. Mazar A.P., Henkin J., and Goldfarb R.H. The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis. Angiogenesis 3 (1999) 15-32
105. McDonnell C.O., Hill A.D., McNamara D.A., Walsh T.N., and Bouchier-Hayes D.J. Tumour micrometastases: the influence of angiogenesis. Eur. J. Surg. Oncol. 26 (2000) 105-115
106. Miles A.J., Knutson J.R., Skubitz A.P., Furcht L.T., McCarthy J.B., and Fields G.B. A peptide model of basement membrane collagen alpha 1 (IV) 531-543 binds the alpha 3 beta 1 integrin. J. Biol. Chem. 270 (1995) 29047-29050
107. Muragaki Y., Abe N., Ninomiya Y., Olsen B.R., and Ooshima A. The human alpha 1(XV) collagen chain contains a large amino-terminal non-triple helical domain with a tandem repeat structure and homology to alpha 1(XVIII) collagen. J. Biol. Chem. 269 (1994) 4042-4046
108. Muragaki Y., Timmons S., Griffith C.M., Oh S.P., Fadel B., Quertermous T., and Olsen B.R. Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc. Natl. Acad. Sci. USA 92 (1995) 8763-8767
109. Musso O., Rehn M., Saarela J., Theret N., Lietard J., Hintikka, Lotrian D., Campion J.P., Pihlajaniemi T., and Clement B. Collagen XVIII is localized in sinusoids and basement membrane zones and expressed by hepatocytes and activated stellate cells in fibrotic human liver. Hepatology 28 (1998) 98-107
110. Musso O., Rehn M., Theret N., Turlin B., Bioulac-Sage P., Lotrian D., Campion J.P., Pihlajaniemi T., and Clement B. Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas. Cancer Res. 61 (2001) 45-49
111. Myers J.C., Dion A.S., Abraham V., and Amenta P.S. Type XV collagen exhibits a widespread distribution in human tissues but a distinct localization in basement membrane zones. Cell Tissue Res. 286 (1996) 493-505
112. Myers J.C., Jones T.A., Pohjolainen E.R., Kadri A.S., Goddard A.D., Sheer D., Solomon E., and Pihlajaniemi T. Molecular cloning of alpha 5(IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus. Am. J. Hum. Genet. 46 (1990) 1024-1033
113. Nakahara H., Nomizu M., Akiyama S.K., Yamada Y., Yeh Y., and Chen W.T. A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides. J. Biol. Chem. 271 (1996) 27221-27224
114. Nie J., and Pei D. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond. Cancer Res. 63 (2003) 6758-6762
115. Niki T., Kohno T., Iba S., Moriya Y., Takahashi Y., Saito M., Maeshima A., Yamada T., Matsuno Y., Fukayama M., Yokota J., and Hirohashi S. Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas. Am. J. Pathol. 160 (2002) 1129-1141
116. Nip J., Shibata H., Loskutoff D.J., Cheresh D.A., and Brodt P. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin. J. Clin. Invest. 90 (1992) 1413
117. Oh S.P., Kamagata Y., Muragaki Y., Timmons S., Ooshima A., and Olsen B.R. Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. Proc. Natl. Acad. Sci. USA 91 (1994) 4229-4233
118. Oh S.P., Warman M.L., Seldin M.F., Cheng S.D., Knoll J.H., Timmons S., and Olsen B.R. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 19 (1994) 494-499
119. Ohnishi Y., Tajima S., and Ishibashi A. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells. Eur. J. Dermatol. 11 (2001) 420-423
120. Okegawa T., Pong R.C., Li Y., and Hsieh J.T. The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim. Pol. 51 (2004) 445-457
121. Ono Y., Nakanishi Y., Ino Y., Niki T., Yamada T., Yoshimura K., Saikawa M., Nakajima T., and Hirohashi S. Clinocopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: immunohistochemical analysis of 67 lesions. Cancer 85 (1999) 2315-2321
122. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., and Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277-285
123. O'Reilly M.S., Wiederschain D., Stetler-Stevenson W.G., Folkman J., and Moses M.A. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance [In Process Citation]. J. Biol. Chem. 274 (1999) 29568-29571
124. Panka D.J., and Mier J.W. Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells. J. Biol. Chem. 278 (2003) 37632-37636
125. Pasco S., Han J., Gillery P., Bellon G., Maquart F.X., Borel J.P., Kefalides N.A., and Monboisse J.C. A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells. Cancer Res. 60 (2000) 467-473
126. Pasco S., Monboisse J.C., and Kieffer N. The alpha 3(IV)185-206 peptide from noncollagenous domain 1 of type IV collagen interacts with a novel binding site on the beta 3 subunit of integrin alpha Vbeta 3 and stimulates focal adhesion kinase and phosphatidylinositol 3-kinase phosphorylation. J. Biol. Chem. 275 (2000) 32999-33007
127. Pasco S., Ramont L., Maquart F.X., and Monboisse J.C. Control of melanoma progression by various matrikines from basement membrane macromolecules. Crit. Rev. Oncol. Hematol. 49 (2004) 221-233
128. Patterson B.C., and Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272 (1997) 28823-28825
129. Petitclerc E., Boutaud A., Prestayko A., Xu J., Sado Y., Ninomiya Y., Sarras Jr. M.P., Hudson B.G., and Brooks P.C. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J. Biol. Chem. 275 (2000) 8051-8061
130. Ponce M.L., Nomizu M., Delgado M.C., Kuratomi Y., Hoffman M.P., Powell S., Yamada Y., Kleinman H.K., and Malinda K.M. Identification of endothelial cell binding sites on the laminin gamma 1 chain. Circ. Res. 84 (1999) 688-694
131. Pozzi A., Moberg P.E., Miles L.A., Wagner S., Soloway P., and Gardner H.A. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc. Natl. Acad. Sci. USA 97 (2000) 2202-2207
132. Pozzi A., Le Vine W.F., and Gardner H.A. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis. Oncogene 21 (2002) 272-281
133. Pozzi A., and Zent R. Integrins: Sensors of extracellular matrix and modulators of cell function. Nephron. Exp. Nephrol. 94 (2003) e77-e84
134. Pyke C., Romer J., Kallunki P., Lund L.R., Ralfkiaer E., Dano K., and Tryggvason K. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am. J. Pathol. 145 (1994) 782-791
135. Pyke C., Salo S., Ralfkiaer E., Romer J., Dano K., and Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 55 (1995) 4132-4139
136. Quaranta V. Motility cues in the tumor microenvironment. Differentiation 70 (2002) 590-598
137. Quatresooz P., Martalo O., and Pierard G.E. Differential expression of alpha1 (IV) and alpha5 (IV) collagen chains in basal-cell carcinoma. J. Cutan. Pathol. 30 (2003) 548-552
138. Ramchandran R., Dhanabal M., Volk R., Waterman M.J., Segal M., Lu H., Knebelmann B., and Sukhatme V.P. Antiangiogenic activity of restin, NC10 domain of human collagen XV: Comparison to endostatin. Biochem. Biophys. Res. Commun. 255 (1999) 735-739
139. Rehn M., Hintikka E., and Pihlajaniemi T. Primary structure of the alpha 1 chain of mouse type XVIII collagen, partial structure of the corresponding gene, and comparison of the alpha 1(XVIII) chain with its homologue, the alpha 1(XV) collagen chain. J. Biol. Chem. 269 (1994) 13929-13935
140. Rehn M., and Pihlajaniemi T. Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc. Natl. Acad. Sci. USA 91 (1994) 4234-4238
141. Rehn M., Veikkola T., Kukk-Valdre E., Nakamura H., Ilmonen M., Lombardo C., Pihlajaniemi T., Alitalo K., and Vuori K. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA 98 (2001) 1024-1029
142. Saarela J., Rehn M., Oikarinen A., Autio-Harmainen H., and Pihlajaniemi T. The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am. J. Pathol. 153 (1998) 611-626
143. Sang Q.X. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 8 (1998) 171-177
144. Sasaki T., Larsson H., Tisi D., Claesson-Welsh L., Hohenester E., and Timpl R. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J. Mol. Biol. 301 (2000) 1179-1190
145. Sathyanarayana U.G., Padar A., Suzuki M., Maruyama R., Shigematsu H., Hsieh J.T., Frenkel E.P., and Gazdar A.F. Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res. 9 (2003) 6395-6400
146. Sato H., and Seiki M. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J. Biochem. (Tokyo) 119 (1996) 209-215
147. Schenk S., Hintermann E., Bilban M., Koshikawa N., Hojilla C., Khokha R., and Quaranta V. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J. Cell. Biol. 161 (2003) 197-209
148. Schwartz M.A., Schaller M.D., and Ginsberg M.H. Integrins: emerging paradigms of signal transduction. Ann. Rev. Cell. Dev. Biol. 11 (1995) 549-599
149. Senger D.R., Claffey K.P., Benes J.E., Perruzzi C.A., Sergiou A.P., and Detmar M. Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA 94 (1997) 13612-13617
150. Shahan T.A., Ohno N., Pasco S., Borel J.P., Monboisse J.C., and Kefalides N.A. Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP. Connect. Tissue Res. 40 (1999) 221-232
151. Sidenius N., and Blasi F. The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy. Cancer Metastasis Rev. 22 (2003) 205-222
152. Siewinski M., Saleh Y., and Ziolkowski P. Cysteine peptidases in health and diseases. Folia. Med. Cracov. 44 (2003) 169-178
153. Skubitz A.P., Bast Jr. R.C., Wayner E.A., Letourneau P.C., and Wilke M.S. Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Am. J. Pathol. 148 (1996) 1445-1461
154. Skyldberg B., Salo S., Eriksson E., Aspenblad U., Moberger B., Tryggvason K., and Auer G. Laminin-5 as a marker of invasiveness in cervical lesions. J. Natl. Cancer. Inst. 91 (1999) 1882-1887
155. Sloane B.F., and Honn K.V. Cysteine proteinases and metastasis. Cancer Metastasis Rev. 3 (1984) 249-263
156. Sloane B.F., Rozhin J., Krepela E., Ziegler G., and Sameni M. The malignant phenotype and cysteine proteinases. Biomed. Biochim. Acta. 50 (1991) 549-554
157. Soininen R., Haka-Risku T., Prockop D.J., and Tryggvason K. Complete primary structure of the alpha 1-chain of human basement membrane (type IV) collagen. FEBS Lett. 225 (1987) 188-194
158. Stamenkovic I. Extracellular matrix remodelling: The role of matrix metalloproteinases. J. Pathol. 200 (2003) 448-464
159. Stetler-Stevenson W.G., and Yu A.E. Proteases in invasion: Matrix metalloproteinases. Semin. Cancer Biol. 11 (2001) 143-152
160. Tagliabue E., Ghirelli C., Squicciarini P., Aiello P., Colnaghi M.I., and Menard S. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin. Cancer Res. 4 (1998) 407-410
161. Timpl R., Wiedemann H., van Delden V., Furthmayr H., and Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur. J. Biochem. 120 (1981) 203-211
162. Udayakumar T.S., Chen M.L., Bair E.L., Von Bredow D.C., Cress A.E., Nagle R.B., and owden G.T. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res. 63 (2003) 2292-2299
163. Ura H., Denno R., Hirata K., Yamaguchi K., and Yasoshima T. Separate functions of alpha2beta1 and alpha3beta1 integrins in the metastatic process of human gastric carcinoma. Surg. Today 28 (1998) 1001-1006
164. Vandenberg P., Kern A., Ries A., Luckenbill-Edds L., Mann K., and Kuhn K. Characterization of a type IV collagen major cell binding site with affinity to the alpha 1 beta 1 and the alpha 2 beta 1 integrins. J. Cell. Biol. 113 (1991) 1475-1483
165. Wickstrom S.A., Alitalo K., and Keski-Oja J. An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J. Biol. Chem. 279 (2004) 20178-20185
166. Wilson R.F., Morse M.A., Pei P., Renner R.J., Schuller D.E., Robertson F.M., and Mallery S.R. Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer. Res. 23 (2003) 1289-1295
167. Yamamoto H., Itoh F., Iku S., Hosokawa M., and Imai K. Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Clin. Cancer Res. 7 (2001) 896-900
168. Yan S., Sameni M., and Sloane B.F. Cathepsin B and human tumor progression. Biol. Chem. 379 (1998) 113-123
169. Yang C., Zeisberg M., Lively J.C., Nyberg P., Afdhal N., and Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res. 63 (2003) 8312-8317
170. Ziaie Z., Fawzi A., Bellon G., Monboisse J.C., and Kefalides N.A. A peptide of the alpha3 chain of type IV collagen protects basement membrane against damage by PMN. Biochem. Biophys. Res. Commun. 261 (1999) 247-250